Chargement en cours...
Targeting B cells for the treatment of SLE: The beginning of the end or the end of the beginning?
Systemic Lupus Erythematosus (SLE) is a systemic autoimmune disease for which therapeutic advances in immunosuppressive and support therapy have significantly improved survival over the last 5 decades. Unfortunately, SLE still carries substantially increased rates of mortality and end stage renal di...
Enregistré dans:
| Publié dans: | Discov Med |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2010
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4557964/ https://ncbi.nlm.nih.gov/pubmed/21122473 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|